Notably, CRP was associated with a greater likelihood of meeting criteria for a range of clinical outcomes, with a numerically greater likelihood consistently reported for depression as compared to anxiety at baseline and first follow-up assessment. The gene discussed is CRP; the disease is depressive symptom measurement.